{"id":22585,"date":"2020-12-03T08:14:20","date_gmt":"2020-12-03T07:14:20","guid":{"rendered":"https:\/\/www.satt.fr\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/"},"modified":"2020-12-03T08:14:20","modified_gmt":"2020-12-03T07:14:20","slug":"creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/","title":{"rendered":"Cr\u00e9ation de la startup LAMINA THERAPEUTICS,  propuls\u00e9e par la SATT Conectus"},"content":{"rendered":"<p><strong><span style=\"color: #800000;\">Strasbourg compte une nouvelle startup sur ses terres d\u2019excellence scientifique : LAMINA THERAPEUTICS, bas\u00e9e sur une technologie innovante issue de l\u2019INSERM et de l\u2019Universit\u00e9 de Strasbourg, soutenue par la SATT CONECTUS. Cette startup d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de dispositifs m\u00e9dicaux implantables pour la m\u00e9decine r\u00e9g\u00e9n\u00e9rative.<\/span> <\/strong><\/p>\n<div id=\"attachment_22564\" style=\"width: 177px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-22564\" class=\"size-full wp-image-22564\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Image1.png\" alt=\"\" width=\"167\" height=\"223\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Image1.png 167w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Image1-112x150.png 112w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Image1-75x100.png 75w\" sizes=\"auto, (max-width: 167px) 100vw, 167px\" \/><p id=\"caption-attachment-22564\" class=\"wp-caption-text\">\u00a9Laboratoire RNM<\/p><\/div>\n<p>L&#8217;innovation est prometteuse : elle pourrait ouvrir <strong>de nouvelles voies th\u00e9rapeutiques dans le domaine de la r\u00e9g\u00e9n\u00e9ration de l\u2019os et du cartilage pour traiter notamment l\u2019arthrose<\/strong>, qui touche plusieurs centaines de millions de personnes dans le monde.<\/p>\n<p>Cr\u00e9\u00e9e en septembre 2020, LAMINA THERAPEUTICS repose sur les travaux de recherche de l\u2019\u00e9quipe scientifique strasbourgeoise coordonn\u00e9e par la <strong>Pr. Nadia JESSEL, Directrice de l\u2019unit\u00e9 INSERM UMR 1260 \/ Laboratoire RNM<\/strong> (Nano M\u00e9decine R\u00e9g\u00e9n\u00e9rative) et membre fondateur de LAMINA THERAPEUTICS.<\/p>\n<p>Cette technologie novatrice vise le d\u00e9veloppement d\u2019une nouvelle g\u00e9n\u00e9ration de Dispositif M\u00e9dical de Th\u00e9rapie Innovante (DMTI) pour la m\u00e9decine r\u00e9g\u00e9n\u00e9rative et plus particuli\u00e8rement pour la<strong> reconstruction de l\u2019os, du cartilage et de l\u2019unit\u00e9 ost\u00e9ochondrale<\/strong>.<\/p>\n<ul>\n<li><strong>Nadia JESSEL<\/strong> en confirme le potentiel majeur : <em>\u00ab Notre technologie comprend un pansement biod\u00e9gradable tridimensionnel comportant des nano-r\u00e9servoirs de produits actifs et associ\u00e9 \u00e0 des cellules souches issues du patient. Cette combinaison innovante permet une reconstitution plus rapide et en profondeur de l\u2019os et du cartilage d\u2019autant qu\u2019elle reproduit plus fid\u00e8lement ce qui se passe dans le corps humain. Elle \u00e9vitera au patient de subir une intervention chirurgicale lourde \u00bb<\/em>.\n<\/li>\n<\/ul>\n<p><strong><span style=\"font-size: 14pt; color: #800000;\">Du labo \u00e0 la startup<\/span><\/strong><\/p>\n<p>C\u2019est en 2011 que l\u2019aventure de la valorisation des travaux de recherche de Nadia JESSEL d\u00e9marre, avec un premier investissement financier du r\u00e9seau de valorisation Conectus Alsace, g\u00e9n\u00e9rant le d\u00e9p\u00f4t d\u2019un premier brevet cette m\u00eame ann\u00e9e. <strong>La SATT CONECTUS &#8211; cr\u00e9\u00e9e en 2012 &#8211; prend ensuite le relais et investit 450 000 euros<\/strong> en 2014 dans un projet de maturation. C\u2019est \u00e0 ce moment-l\u00e0 que cette technologie innovante prend v\u00e9ritablement son envol comme le souligne <strong>Caroline DREYER, Pr\u00e9sidente de la SATT CONECTUS<\/strong> :<\/p>\n<ul>\n<li><em>\u00ab Une d\u00e9couverte scientifique d\u2019exception ne suffit pas pour rendre une innovation accessible \u00e0 tous. Il faut l\u2019amener \u00e0 un stade de d\u00e9veloppement qui r\u00e9ponde au plus pr\u00e8s aux besoins r\u00e9els des utilisateurs finaux. Pour cela, il faut la tester, l\u2019optimiser, s\u2019assurer qu\u2019elle est en ad\u00e9quation avec les requis r\u00e9glementaires et enfin la rendre technologiquement industrialisable \u00e0 grande \u00e9chelle. C\u2019est ce que CONECTUS a permis en investissant sur ce projet innovant, pr\u00e9curseur de la startup LAMINA THERAPEUTICS. &#8220;. Le projet b\u00e9n\u00e9ficie \u00e9galement du soutien de la R\u00e9gion Grand Est et du FEDER, ainsi que de l\u2019ANR.<\/em><\/li>\n<\/ul>\n<p><strong>L\u2019investissement financier de la SATT CONECTUS permet alors de gagner en maturit\u00e9 technologique gr\u00e2ce \u00e0 la r\u00e9alisation d\u2019une mont\u00e9e en \u00e9chelle de la fabrication des membranes, suivie d\u2019\u00e9tudes de biocompatibilit\u00e9 et d\u2019efficacit\u00e9 pr\u00e9clinique.\u00a0<\/strong><\/p>\n<p>Le projet b\u00e9n\u00e9ficie \u00e9galement du <strong>soutien de la R\u00e9gion Grand Est et du FEDER, ainsi que de l\u2019ANR.<\/strong><\/p>\n<p>Le projet avance ainsi pas \u00e0 pas, au point de pouvoir envisager, en 2019, la cr\u00e9ation d\u2019une startup d\u00e9di\u00e9e : LAMINA THERAPEUTICS. Gr\u00e2ce \u00e0 son programme <strong>Team-to-market.fr<\/strong> soutenu par la R\u00e9gion Grand Est, <strong>la SATT CONECTUS finance fin 2019 une expertise qui permet d\u2019\u00e9tablir les bases d\u2019un premier business plan<\/strong> qui identifie toutes les phases pr\u00e9paratoires \u00e0 la cr\u00e9ation de l\u2019entreprise. Cela permet \u00e0 la SATT CONECTUS d\u2019acc\u00e9l\u00e9rer l\u2019aventure. En effet, <strong>ses experts mettent alors en relation la chercheuse Nadia JESSEL avec<\/strong> <strong>NLC, un acc\u00e9l\u00e9rateur de startup europ\u00e9en sp\u00e9cialis\u00e9 dans les dispositifs m\u00e9dicaux<\/strong> et les produits pharmaceutiques, qui va permettre de dresser l\u2019ossature de la future startup et de structurer une \u00e9quipe robuste.<\/p>\n<p><span style=\"color: #800000; font-size: 14pt;\"><strong>Une entr\u00e9e en phase clinique d\u00e8s 2021<\/strong><\/span><\/p>\n<p>\nAujourd\u2019hui, LAMINA THERAPEUTICS s\u2019appuie sur une solide \u00e9quipe qui comptera <strong>8 collaborateurs<\/strong> \u00e0 horizon 2021. Son activit\u00e9 repose sur <strong>3 familles de brevets<\/strong>. De plus, elle b\u00e9n\u00e9ficie maintenant du <strong>soutien de Bpifrance<\/strong> qui vient de lui octroyer une aide Deeptech.<\/p>\n<p>La startup finalise actuellement le dossier r\u00e9glementaire et compte initier les <strong>premiers essais cliniques en 2021<\/strong> pour le traitement de l\u00e9sions ost\u00e9o-cartilagineuses isol\u00e9es du genou.<\/p>\n<ul>\n<li><strong>Ineke RIJNHOUT, CEO de LAMINA THERAPEUTICS<\/strong>, confirme le challenge : <em>\u201cLa technologie de notre plateforme va r\u00e9volutionner le traitement de millions de patients souffrant de graves d\u00e9fauts du cartilage et des os, en favorisant une vie active et une qualit\u00e9 de vie \u00e9lev\u00e9e. Les strat\u00e9gies cliniques actuelles ne sont souvent ni efficaces ni durables, d&#8217;o\u00f9 l\u2019important besoin de technologies innovantes pour pr\u00e9venir efficacement la d\u00e9gradation du cartilage \u00e0 un stade pr\u00e9coce. Notre kit lamina.ONE implantable et pr\u00eat \u00e0 l&#8217;emploi est facile \u00e0 appliquer gr\u00e2ce \u00e0 une proc\u00e9dure chirurgicale courte et mini-invasive, ce qui se traduit par un temps de r\u00e9cup\u00e9ration tr\u00e8s court pour le patient. LAMINA THERAPEUTICS vise \u00e0 \u00eatre une entreprise leader dans le domaine de la r\u00e9g\u00e9n\u00e9ration en fournissant des solutions innovantes de nanostructures pour des besoins m\u00e9dicaux \u00e9lev\u00e9s non satisfaits dans les domaines de l&#8217;orthop\u00e9die, des indications maxillo-faciales et parodontales. LAMINA THERAPEUTICS a \u00e9tabli de solides collaborations avec plusieurs partenaires industriels et universitaires, et recherche en permanence \u00e0 \u00e9tablir des partenariats strat\u00e9giques \u00e0 forte valeur ajout\u00e9e pour renforcer son portefeuille. \u00bb<\/em><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.conectus.fr\/sites\/default\/files\/2020-12\/CP_FR_CREATION%20STARTUP%20LAMINA_DEF.docx_.pdf\"><strong><span style=\"color: #800000;\">LIRE LE COMMUNIQUE DE PRESSE DANS SON INTEGRALITE<\/span><\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Strasbourg compte une nouvelle startup sur ses terres d\u2019excellence scientifique : LAMINA THERAPEUTICS, bas\u00e9e sur une technologie innovante issue de l\u2019INSERM et de l\u2019Universit\u00e9 de Strasbourg, soutenue par la SATT CONECTUS. Cette startup d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de dispositifs m\u00e9dicaux implantables pour la m\u00e9decine r\u00e9g\u00e9n\u00e9rative. L&#8217;innovation est prometteuse : elle pourrait ouvrir de nouvelles voies [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":22568,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,568,604],"tags":[],"class_list":["post-22585","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-successstories-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France MANDRY\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/\"},\"author\":{\"name\":\"France MANDRY\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"headline\":\"Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus\",\"datePublished\":\"2020-12-03T07:14:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/\"},\"wordCount\":957,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg\",\"articleSection\":[\"News\",\"Success Stories\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/\",\"url\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/\",\"name\":\"Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg\",\"datePublished\":\"2020-12-03T07:14:20+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg\",\"width\":2304,\"height\":3072},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\",\"name\":\"France MANDRY\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/france\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/","twitter_misc":{"Written by":"France MANDRY","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/"},"author":{"name":"France MANDRY","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"headline":"Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus","datePublished":"2020-12-03T07:14:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/"},"wordCount":957,"image":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg","articleSection":["News","Success Stories","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/","url":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/","name":"Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg","datePublished":"2020-12-03T07:14:20+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/LAMINA\u00a9Laboratoire-RNM.jpg","width":2304,"height":3072},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Cr\u00e9ation de la startup LAMINA THERAPEUTICS, propuls\u00e9e par la SATT Conectus"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e","name":"France MANDRY","url":"https:\/\/www.satt.fr\/en\/author\/france\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/22585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=22585"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/22585\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/22568"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=22585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=22585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=22585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}